BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xu S, Shu P, Zou S, Shen X, Qu Y, Zhang Y, Sun K, Zhang J. NFATc1 is a tumor suppressor in hepatocellular carcinoma and induces tumor cell apoptosis by activating the FasL-mediated extrinsic signaling pathway. Cancer Med 2018;7:4701-17. [PMID: 30085405 DOI: 10.1002/cam4.1716] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang J, Zhang Y, Liu L, Cui Z, Shi R, Hou J, Liu Z, Yang L, Wang L, Li Y. NFAT2 overexpression suppresses the malignancy of hepatocellular carcinoma through inducing Egr2 expression. BMC Cancer 2020;20:966. [PMID: 33023539 DOI: 10.1186/s12885-020-07474-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
2 Wang J, Zhao H, Zheng L, Zhou Y, Wu L, Xu Y, Zhang X, Yan G, Sheng H, Xin R, Jiang L, Lei J, Zhang J, Chen Y, Peng J, Chen Q, Yang S, Yu K, Li D, Xie Q, Li Y. FGF19/SOCE/NFATc2 signaling circuit facilitates the self-renewal of liver cancer stem cells. Theranostics 2021;11:5045-60. [PMID: 33754043 DOI: 10.7150/thno.56369] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
3 Li W, Li Q, Wei L, Pan X, Huang D, Gan J, Tang S. Rosmarinic Acid Analogue-11 Induces Apoptosis of Human Gastric Cancer SGC-7901 Cells via the Epidermal Growth Factor Receptor (EGFR)/Akt/Nuclear Factor kappa B (NF-κB) Pathway. Med Sci Monit Basic Res 2019;25:63-75. [PMID: 30799435 DOI: 10.12659/MSMBR.913331] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
4 Song J, Zou D, Zhao X, Chen Y, Lv F, Wang S, Sui D, Han Q, Yang C, Wang X, Liu B, Deng M, Zhang Y. Bufalin inhibits human diffuse large B-cell lymphoma tumorigenesis by inducing cell death through the Ca2+/NFATC1/cMYC pathway. Carcinogenesis 2021;42:303-14. [PMID: 33124657 DOI: 10.1093/carcin/bgaa108] [Reference Citation Analysis]
5 Yao J, Zhang X, Li J, Zhao D, Gao B, Zhou H, Gao S, Zhang L. Silencing TRIP13 inhibits cell growth and metastasis of hepatocellular carcinoma by activating of TGF-β1/smad3. Cancer Cell Int 2018;18:208. [PMID: 30564064 DOI: 10.1186/s12935-018-0704-y] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
6 Iyer RV, Maguire O, Kim M, Curtin LI, Sexton S, Fisher DT, Schihl SA, Fetterly G, Menne S, Minderman H. Dose-Dependent Sorafenib-Induced Immunosuppression Is Associated with Aberrant NFAT Activation and Expression of PD-1 in T Cells. Cancers (Basel). 2019;11. [PMID: 31100868 DOI: 10.3390/cancers11050681] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
7 Vitobello A, Perner J, Beil J, Zhu J, Del Río-Espínola A, Morawiec L, Westphal M, Dubost V, Altorfer M, Naumann U, Mueller A, Kapur K, Borowsky M, Henderson C, Wolf CR, Schwarz M, Moggs J, Terranova R. Drug-induced chromatin accessibility changes associate with sensitivity to liver tumor promotion. Life Sci Alliance 2019;2:e201900461. [PMID: 31615920 DOI: 10.26508/lsa.201900461] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Xu S, Shu P, Zou S, Shen X, Qu Y, Zhang Y, Sun K, Zhang J. NFATc1 is a tumor suppressor in hepatocellular carcinoma and induces tumor cell apoptosis by activating the FasL-mediated extrinsic signaling pathway. Cancer Med 2018;7:4701-17. [PMID: 30085405 DOI: 10.1002/cam4.1716] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
9 Ma J, Du R, Huang Y, Zhong W, Gui H, Mao C, Song X, Lu J. Expression, Prognosis and Gene Regulation Network of NFAT Transcription Factors in Non-Small Cell Lung Cancer. Pathol Oncol Res 2021;27:529240. [PMID: 34257525 DOI: 10.3389/pore.2021.529240] [Reference Citation Analysis]
10 Masaki T, Shimada M. Decoding the Phosphatase Code: Regulation of Cell Proliferation by Calcineurin. Int J Mol Sci 2022;23:1122. [PMID: 35163061 DOI: 10.3390/ijms23031122] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 Xie H, Liu S, Zhang Z, Chen P, Tao Y. A novel seven-gene signature as Prognostic Biomarker in Hepatocellular Carcinoma. J Cancer 2020;11:5768-81. [PMID: 32913470 DOI: 10.7150/jca.44573] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Xie ZY, Dong W, Zhang L, Wang MJ, Xiao ZM, Zhang YH, Shi WX, Huang Y, Yang Y, Li CL, Fu L, Zhao XC, Li RZ, Li ZL, Chen YH, Ye ZM, Liu SX, Dong Z, Liang XL. NFAT inhibitor 11R-VIVIT ameliorates mouse renal fibrosis after ischemia-reperfusion-induced acute kidney injury. Acta Pharmacol Sin 2021. [PMID: 34937917 DOI: 10.1038/s41401-021-00833-y] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
13 He C, Shi W, Li R, Zhang L. [NFAT2 mediates high glucose-induced apoptosis in glomerular podocytes in vitro]. Nan Fang Yi Ke Da Xue Xue Bao 2018;38:1270-6. [PMID: 30377135 DOI: 10.3969/j.issn.1673-4254.2018.10.20] [Reference Citation Analysis]
14 Zhang Z, Wen H, Yang X, Zhang K, He B, Zhang X, Kong L. Stimuli and Relevant Signaling Cascades for NFATc1 in Bone Cell Homeostasis: Friend or Foe? CSCR 2019;14:239-43. [DOI: 10.2174/1574888x14666181205122729] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
15 Du Z, Yan D, Li Z, Gu J, Tian Y, Cao J, Tang Z. Genes Involved in the PD-L1 Pathway Might Associate with Radiosensitivity of Patients with Gastric Cancer. J Oncol 2020;2020:7314195. [PMID: 32963532 DOI: 10.1155/2020/7314195] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
16 Lin Z, Xu Q, Song X, Zeng Y, Zeng L, Zhao L, Xu J, Miao D, Chen Z, Yu F. Comprehensive Analysis Identified Mutation-Gene Signature Impacts the Prognosis Through Immune Function in Hepatocellular Carcinoma. Front Oncol 2022;12:748557. [DOI: 10.3389/fonc.2022.748557] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]